Apyx Medical Corp (APYX) insider trading

Every open-market stock purchase and sale by Apyx Medical Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Matthew C Hill (CFO), $6.8K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.41 on Oct 22, 2026.

Recent APYX insider trades

DateInsiderTradeValue
Jun 30, 2026Lawrence Waldman (Director)Bought (not open market)$22.6K
Jun 30, 2026Lawrence Waldman (Director)Sold (not open market)$22.6K
Jun 30, 2026Lawrence Waldman (Director)Bought (not open market)—
Jun 15, 2026Shawn David Roman (COO)Sold (not open market)$48.5K
Jun 15, 2026Shawn David Roman (COO)Bought (not open market)—
Jun 11, 2026Charles D. Goodwin II (CEO)Bought (not open market)—
Jun 11, 2026Stavros G. Vizirgianakis (Director)Bought (not open market)—
Jun 11, 2026Wendy Lauren Levine (Director)Bought (not open market)—
Jun 11, 2026Lawrence Waldman (Director)Bought (not open market)—
Jun 11, 2026Moshe Citronowicz (Officer)Bought (not open market)—
Jun 11, 2026Matthew C Hill (CFO)Bought (not open market)—
Jun 11, 2026Minnie Baylor-Henry (Director)Bought (not open market)—
Jun 11, 2026Shawn David Roman (COO)Bought (not open market)—
Mar 15, 2026Moshe Citronowicz (President)Bought (not open market)—
Jan 27, 2026Shawn David Roman (COO)Bought (not open market)—

Who's trading APYX

Get free alerts when an insider at Apyx Medical Corp files a new trade →